News
ZURICH, Sept 14 (Reuters) - Swiss drugmaker Roche ROG.S on Monday said two-thirds of spinal muscular atrophy (SMA) patients who have begun taking its new medicine Evrysdi have previously got rival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results